0 reactions
indianmarketgrid The company no longer expects a near-term approval resubmission, although the affected trial participants remain asymptomatic and stable.
READ FULL ANALYSIS MEMBER ANALYSIS
THE IMG COMMUNITY
Market insights. Fresh perspectives. Your conversation.
indianmarketgrid The company no longer expects a near-term approval resubmission, although the affected trial participants remain asymptomatic and stable.